Discontinued — last reported Q3 '23

Supplemental

Interest Paid

Oracle Interest Paid remained flat by 0.0% to $843.50M in Q2 2025 compared to the prior quarter. Year-over-year, this metric declined by 7.7%, from $913.75M to $843.50M. Over 3 years (FY 2022 to FY 2025), Interest Paid shows an upward trend with a 9.1% CAGR. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementCash Flow Statement
SectionSupplemental
CategoryLeverage
SignalLower is better
VolatilityStable
First reportedQ4 2013
Last reportedQ3 2023

How to read this metric

An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.

Detailed definition

The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...

Peer comparison

Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.

Metric ID: cf_interest_paid

Historical Data

4 years
 FY'22FY'23FY'24FY'25
Value$2.65B$3.12B$3.55B$3.44B
YoY Change+17.6%+13.9%-3.1%
Range$2.65B$3.55B
CAGR+9.1%
Avg YoY Growth+9.5%
Median YoY Growth+13.9%

Frequently Asked Questions

What is Oracle's interest paid?
Oracle (ORCL) reported interest paid of $843.50M in Q2 2025.
How has Oracle's interest paid changed year-over-year?
Oracle's interest paid decreased by 7.7% year-over-year, from $913.75M to $843.50M.
What is the long-term trend for Oracle's interest paid?
Over 3 years (2022 to 2025), Oracle's interest paid has grown at a 9.1% compound annual growth rate (CAGR), from $2.65B to $3.44B.
What does interest paid mean?
The actual cash paid to lenders for interest on debt.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.